Profil bibliographique

Christina Rautenberg

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

85Publications signalées

1130Citations signalées

3Affiliations récentes

Institutions déclarées

West Cancer Center Essen University Hospital West German Heart and Vascular Center Essen

Domaines associés

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia Treatments

Publications récentes

Accès ouvert 2026 articleOpenAlex

Treatment of Herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient

Catherina Lueck, Christina Rautenberg, Alexander Birkmann, Susanne Bonsmann et autres

0 citationsnpj Antimicrobials and Resistance

Accès ouvert 2026 articleOpenAlex

Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation

Nico Gagelmann, Gabriela S. Hobbs, Edoardo Campodonico, Grzegorz Helbig et autres

0 citationsDiRROS repository (University of Maribor)

Accès ouvert 2026 articleOpenAlex

Allogeneic Transplantation in the Rare Disease Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Neutrophilia: Age and Disease Burden Determine Outcome

Annemarie Mohring, Katja Sockel, Christian Thiede, Jan Schröder et autres

0 citationsTransplantation and Cellular Therapy

2026 articleOpenAlex

PTCy or ATG for Matched Transplantation in Myelofibrosis

Patrizia Chiusolo, Andrea Bacigalupo, Rachel B. Salit, Thomas Schroeder et autres

1 citationAmerican Journal of Hematology

Accès ouvert 2025 articleOpenAlex

Multicenter validation of the newly developed Concise Objectifiable Risk Evaluation (CORE) score also confirms its ability to complement the Hematopoietic Cell Comorbidity Index (HCT-CI)

G Weise, Christina Rautenberg, Alexander Denk, Radwan Massoud et autres

1 citationBone Marrow Transplantation

Accès ouvert 2025 articleOpenAlex

Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group

Christina Rautenberg, Matthias Stelljes, Gesine Bug, Udo Holtick et autres

3 citationsTransplantation and Cellular Therapy

Accès ouvert 2025 conference-abstractOpenAlex

Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic gvhd treatment: Multicenter retrospective analysis of a large german-austrian cohort of the belumosudil managed-access program.

Udo Holtick, Elisa Sala, Katharina Egger‐Heidrich, Silke Heidenreich et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Multicenter Phase II trial of enasidenib as maintenance treatment following allogeneic stem cell transplantation in IDH2-mutated myeloid neoplasms – the IDH2-post-allo-trial (NCT04522895)

Thomas Schroeder, Matthias Stelljes, Edgar Jost, Jan Moritz Middeke et autres

0 citationsBlood

2025 conference-abstractOpenAlex

An integrative prognostic model for transplant outcomes in myelofibrosis

Nico Gagelmann, Thomas Schroeder, Rachel B. Salit, Carmelo Gurnari et autres

0 citationsBlood

Accès ouvert 2025 articleOpenAlex

Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission

Jacob Pyka, Judith Metzdorf, Christian Reicherts, Julia Marx et autres

1 citationTransplantation and Cellular Therapy

Accès ouvert 2025 articleOpenAlex

Outcome after Treosulfan-based conditioning in a real-world MDS cohort

Christina Rautenberg, Jacob Pyka, Tim Lohmann, Jennifer Kaivers et autres

0 citationsBone Marrow Transplantation

2025 articleOpenAlex

Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party

Dražen Pulanić, Christophe Peczynski, William Boreland, Christina Rautenberg et autres

4 citationsBone Marrow Transplantation

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.